Completed
A Phase 2 Study of E6011 in Subjects With Rheumatoid Arthritis Inadequately Responding to Biologics
NCT02960490
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
- Locations
-
- Eisai Trial Site #1 Yotsukaidō, Chiba, Japan
- Eisai Trial Site #1 Matsuyama, Ehime, Japan
- Eisai Trial Site #1 Kitakyushu, Fukuoka, Japan
- Eisai Trial Site #1 Takasaki, Gunma, Japan